Sarepta
Sarepta
Genetic medicine company
Gene Therapy
Drug Development
Clinical Research
Molecular Biology
Biostatistics
Open roles at Sarepta
0 open roles
No open positions at this time
Products and services
EXONDYS 51
Antisense Oligonucleotide
EL
ELEVIDYS
Gene Therapy
VY
Vyondys 53
Antisense Oligonucleotide
VILTEPSO
Antisense Oligonucleotide
AM
Amondys 45
Antisense Oligonucleotide
LI
Limb-girdle Muscular Dystrophy Programs
Gene Therapy
SR
SRP-9001
Gene Therapy
CA
CASIMERSEN
RNA-targeted Therapy
CH
Charcot-Marie-Tooth Disease Programs
Neuromuscular Therapy
SR
SRP-5051
Antisense Oligonucleotide
RNA-targeted therapeutics platform
Platform Technology
Similar companies
Illumina
Unlocking the power of the genome.
San Diego, California
5,001-10,000 employees
Public
Valuation $36.0B
220 open jobs
CRISPR Therapeutics
Leading company in the technology industry
Cambridge, Massachusetts, United States
201-500 employees
Public
Valuation $2.9B
14 open jobs
Grail
Biotechnology company.
Menlo Park, California founded
201-500 employees
Private
Valuation $3.2B
29 open jobs
Eli Lilly
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries
Indianapolis, Indiana
10,001+ employees
Public
Valuation $588B
768 open jobs
Ginkgo Bioworks
category:Biotechnology
Boston, MA
501-1,000 employees
Public
Valuation $2.5B
12 open jobs
Latest updates
All
X
News
HN
YouTube
Sarepta Therapeutics (NASDAQ: SRPT) outlines 2026 equity and ESPP plus CEO transition - Stock Titan
Stock Titan
News
·
1 month ago
H.C. Wainwright reiterates Sarepta stock Sell rating at $5 target - Investing.com
Investing.com
News
·
1 month ago
Will Roche’s New Global Elevidys Phase 3 Trial Shift Sarepta Therapeutics' (SRPT) Gene Therapy Narrative? - simplywall.st
simplywall.st
News
·
1 month ago
Sarepta/ Roche Duchenne therapy to face new late-stage trial targeting EU nod - Seeking Alpha
Seeking Alpha
News
·
1 month ago
Roche to start new Elevidys study following setback in Europe - BioPharma Dive
BioPharma Dive
News
·
1 month ago
Show 15 more
Total Views
0
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
Reviews
3.7
10 reviews
Work-life balance
3.2
Compensation
2.8
Culture
4.1
Career
3.4
Management
2.5
65%
Recommend to a friend
Pros
Supportive and collaborative team environment
Cutting-edge research and innovative projects
Good work-life balance and flexible hours
Cons
Below industry standard salary and underpaid entry-level positions
Lack of direction from management
High stress and overwhelming expectations
Salary Ranges
47 data points
Director
Mid/L4
Senior/L5
Director
3 reports
$243,750
total per year
Base
$187,500
Stock
-
$240,500
$247,000
Interview experience
5 interviews
Difficulty
2.2
/ 5
Duration
2-5w
Offer rate
40%
Experience
Positive 60%
Neutral 20%
Negative 20%
Interview process
1
Application Review
2
HR/Recruiter Screen
3
Technical/Phone Screen
4
Hiring Manager Interview
5
Panel/Onsite Interviews
6
Offer
Contact and location